
Researchers from the University of Miami Miller School of Medicine's Sylvester Comprehensive Cancer Center have secured an $800,000 grant from the U.S. Department of Defense (DoD) to combat chemotherapy resistance in pancreatic cancer. The grant will fund a three-year study examining the interaction between myeloid-derived suppressor cells (MDSCs) and cancer-associated fibroblasts (CAFs) within the tumor microenvironment, aiming to develop an innovative nanoengineered immunotherapy to disrupt their signaling pathways.
Like
Save
Share